A class action against implant maker Exactech has been stayed in light of its US bankruptcy, but a carve out allows the firm that brought the case to continue settlement negotiations.
High Court asked to weigh in on ‘public purpose’ for land acquisition
Baker McKenzie partner returns from Hogan Lovells
Judge trims funder’s cut in $38M Mayne Pharma class action settlement
Save (1) Please login to bookmark Close Username or Email Address Password Remember Me A judge has signed off on a $38 million settlement in a shareholder class action against Mayne Pharma but has slashed a 27.9 per cent commission for the funder that backed the case. Victorian Supreme Court Justice Andrew Watson approved the…